{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:54:07Z","timestamp":1777974847797,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foshan\u00a0science\u00a0and\u00a0technology\u00a0plan\u00a0project","award":["No.\u00a02320001006088"],"award-info":[{"award-number":["No.\u00a02320001006088"]}]},{"name":"Guangzhou\u00a0science\u00a0and\u00a0technology\u00a0plan\u00a0project","award":["No.\u00a0202102020024"],"award-info":[{"award-number":["No.\u00a0202102020024"]}]},{"name":"Outstanding\u00a0Youths\u00a0Development\u00a0Scheme\u00a0of\u00a0Nanfang\u00a0Hospital,\u00a0Southern\u00a0Medical\u00a0University","award":["No.\u00a02022J007"],"award-info":[{"award-number":["No.\u00a02022J007"]}]},{"DOI":"10.13039\/501100001809","name":"National\u00a0Natural\u00a0Science\u00a0Foundation\u00a0of\u00a0China","doi-asserted-by":"crossref","award":["No. 81871712"],"award-info":[{"award-number":["No. 81871712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-024-01537-3","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:47:31Z","timestamp":1736311651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients"],"prefix":"10.1007","volume":"25","author":[{"given":"Huijun","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minfeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"8","key":"1537_CR1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"Y-C Hsu","year":"2023","unstructured":"Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"1537_CR2","first-page":"1425","volume":"11","author":"H You","year":"2023","unstructured":"You H, et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J Clin Transl Hepatol. 2023;11(6):1425\u201342.","journal-title":"J Clin Transl Hepatol"},{"issue":"S1","key":"1537_CR3","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1002\/hep.20956","volume":"43","author":"HJ Yim","year":"2006","unstructured":"Yim HJ, Lok AS-F. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology. 2006;43(S1):S173\u201381.","journal-title":"Hepatology"},{"issue":"2","key":"1537_CR4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.21724","volume":"46","author":"CK Hui","year":"2007","unstructured":"Hui CK, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology. 2007;46(2):395\u2013401.","journal-title":"Hepatology"},{"issue":"2","key":"1537_CR5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico P, Agarwal K, Berg T, Buti M, Janssen HL, Papatheodoridis G, Zoulim F, Tacke F. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"issue":"4","key":"1537_CR6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.7150\/ijbs.55724","volume":"17","author":"X Jiang","year":"2021","unstructured":"Jiang X, et al. Paradoxical HBsAg and anti-HBs coexistence among chronic HBV infections: causes and consequences. Int J Biol Sci. 2021;17(4):1125\u201337.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"1537_CR7","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/jmv.24273","volume":"87","author":"F Ding","year":"2015","unstructured":"Ding F, et al. Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsAg and anti-HBs antibodies. J Med Virol. 2015;87(12):2067\u201373.","journal-title":"J Med Virol"},{"issue":"3","key":"1537_CR8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcv.2011.07.011","volume":"52","author":"Y Chen","year":"2011","unstructured":"Chen Y, et al. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs. J Clin Virol. 2011;52(3):198\u2013203.","journal-title":"J Clin Virol"},{"issue":"4","key":"1537_CR9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jvh.12492","volume":"23","author":"Z Pu","year":"2016","unstructured":"Pu Z, et al. Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study. J Viral Hepatitis. 2016;23(4):286\u201393.","journal-title":"J Viral Hepatitis"},{"issue":"1","key":"1537_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jmv.23779","volume":"86","author":"SI Seo","year":"2014","unstructured":"Seo SI, et al. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study. J Med Virol. 2014;86(1):124\u201330.","journal-title":"J Med Virol"},{"issue":"5","key":"1537_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-3148.2001.00323.x","volume":"11","author":"EM Kfoury Baz","year":"2001","unstructured":"Kfoury Baz EM, et al. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific \u2018a\u2019 determinant conformation change and its application in diagnostic assays. Transfus Med. 2001;11(5):355\u201362.","journal-title":"Transfus Med"},{"issue":"9","key":"1537_CR12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jmv.21577","volume":"81","author":"JS Jang","year":"2009","unstructured":"Jang JS, et al. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. J Med Virol. 2009;81(9):1531\u20138.","journal-title":"J Med Virol"},{"issue":"6","key":"1537_CR13","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/JVI.80.6.2968-2975.2006","volume":"80","author":"O Lada","year":"2006","unstructured":"Lada O, et al. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of \u201ca\u201d determinant variants. J Virol. 2006;80(6):2968\u201375.","journal-title":"J Virol"},{"issue":"5","key":"1537_CR14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s005350050379","volume":"34","author":"YM Wang","year":"1999","unstructured":"Wang YM, Ng WC, Lo SK. Detection of pre-S\/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. J Gastroenterol. 1999;34(5):600\u20136.","journal-title":"J Gastroenterol"},{"key":"1537_CR15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2014.11.015","volume":"62","author":"M Pancher","year":"2015","unstructured":"Pancher M, et al. Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification. J Clin Virol. 2015;62:32\u20137.","journal-title":"J Clin Virol"},{"issue":"8","key":"1537_CR16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jmv.24782","volume":"89","author":"X Fu","year":"2017","unstructured":"Fu X, et al. Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection. J Med Virol. 2017;89(8):1419\u201326.","journal-title":"J Med Virol"},{"issue":"3","key":"1537_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/gene.2016.9","volume":"17","author":"XL Hou","year":"2016","unstructured":"Hou XL, et al. Current status and recent advances of next generation sequencing techniques in immunological repertoire. Genes Immun. 2016;17(3):153\u201364.","journal-title":"Genes Immun"},{"issue":"18","key":"1537_CR18","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.7150\/thno.61390","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, et al. The methods and advances of adaptive immune receptors repertoire sequencing. Theranostics. 2021;11(18):8945\u201363.","journal-title":"Theranostics"},{"issue":"5","key":"1537_CR19","first-page":"769","volume":"9","author":"G Wang","year":"2021","unstructured":"Wang G, Duan Z. Guidelines for prevention and treatment of chronic hepatitis B. J Clin Transl Hepatol. 2021;9(5):769\u201391.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"1537_CR20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2007.05.012","volume":"367","author":"P Colson","year":"2007","unstructured":"Colson P, et al. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology. 2007;367(1):30\u201340.","journal-title":"Virology"},{"issue":"W1","key":"1537_CR21","doi-asserted-by":"crossref","first-page":"W39","DOI":"10.1093\/nar\/gkv416","volume":"43","author":"TL Bailey","year":"2015","unstructured":"Bailey TL, et al. The MEME suite. Nucleic Acids Res. 2015;43(W1):W39-49.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1537_CR22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jvh.12492","volume":"23","author":"Z Pu","year":"2016","unstructured":"Pu Z, et al. Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study. J Viral Hepat. 2016;23(4):286\u201393.","journal-title":"J Viral Hepat"},{"issue":"suppl_8","key":"1537_CR23","doi-asserted-by":"crossref","first-page":"S765","DOI":"10.1093\/infdis\/jix356","volume":"216","author":"TC Tseng","year":"2017","unstructured":"Tseng TC, Huang LR. Immunopathogenesis of hepatitis B virus. J Infect Dis. 2017;216(suppl_8):S765-s770.","journal-title":"J Infect Dis"},{"issue":"1","key":"1537_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.icb.7100009","volume":"85","author":"JJ Chang","year":"2007","unstructured":"Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007;85(1):16\u201323.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"1537_CR25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","volume":"48","author":"G Fattovich","year":"2008","unstructured":"Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335\u201352.","journal-title":"J Hepatol"},{"issue":"2","key":"1537_CR26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.23348","volume":"51","author":"YC Chen","year":"2010","unstructured":"Chen YC, Chu CM, Liaw YF. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology. 2010;51(2):435\u201344.","journal-title":"Hepatology"},{"issue":"3","key":"1537_CR27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jvh.12418","volume":"23","author":"V Kim","year":"2016","unstructured":"Kim V, et al. Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis. J Viral Hepat. 2016;23(3):154\u201369.","journal-title":"J Viral Hepat"},{"key":"1537_CR28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-8278(03)00154-5","volume":"39","author":"A Crax\u0131\u0300","year":"2003","unstructured":"Crax\u0131\u0300 A, Di Bona D, Camm\u00e0 C. Interferon-\u03b1 for HBeAg-positive chronic hepatitis. J Hepatol. 2003;39:99\u2013105.","journal-title":"J Hepatol"},{"issue":"9959","key":"1537_CR29","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1537_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22(1):19\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1537_CR31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","volume":"41","author":"JN Stoop","year":"2005","unstructured":"Stoop JN, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology. 2005;41(4):771\u20138.","journal-title":"Hepatology"},{"issue":"6","key":"1537_CR32","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/JVI.79.6.3322-3328.2005","volume":"79","author":"O Franzese","year":"2005","unstructured":"Franzese O, et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol. 2005;79(6):3322\u20138.","journal-title":"J Virol"},{"issue":"1","key":"1537_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/HEP.0000000000000524","volume":"79","author":"P Jiang","year":"2024","unstructured":"Jiang P, et al. Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-\u03b1 in patients with chronic hepatitis B. Hepatol. 2024;79(1):167\u201382.","journal-title":"Hepatol"},{"key":"1537_CR34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molimm.2023.08.005","volume":"162","author":"Z Quan","year":"2023","unstructured":"Quan Z, et al. Altered T-cell receptor \u03b2 repertoire in adults with SARS CoV-2 inactivated vaccine of BBIBP-CorV. Mol Immunol. 2023;162:54\u201363.","journal-title":"Mol Immunol"},{"issue":"5","key":"1537_CR35","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/10\/5\/056001","volume":"10","author":"Y Pickman","year":"2013","unstructured":"Pickman Y, Dunn-Walters D, Mehr R. BCR CDR3 length distributions differ between blood and spleen and between old and young patients, and TCR distributions can be used to detect myelodysplastic syndrome. Phys Biol. 2013;10(5): 056001.","journal-title":"Phys Biol"},{"issue":"1","key":"1537_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.hepres.2006.01.006","volume":"35","author":"X-S Yao","year":"2006","unstructured":"Yao X-S, et al. Analysis of the CDR3 length of TCR \u03b1\u03b2 T cells in the peripheral blood of patients with chronic hepatitis B. Hepatol Res. 2006;35(1):10\u20138.","journal-title":"Hepatol Res"},{"issue":"9","key":"1537_CR37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/eji.201747327","volume":"48","author":"Q Jiang","year":"2018","unstructured":"Jiang Q, et al. Patient-shared TCR\u03b2-CDR3 clonotypes correlate with favorable prognosis in chronic hepatitis B. Eur J Immunol. 2018;48(9):1539\u201349.","journal-title":"Eur J Immunol"},{"issue":"7","key":"1537_CR38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/pathogens11070727","volume":"11","author":"Q Zhan","year":"2022","unstructured":"Zhan Q, et al. T-cell receptor \u03b2; chain and B-cell receptor repertoires in chronic hepatitis B patients with coexisting HBsAg and anti-HBs. Pathogens. 2022;11(7):727.","journal-title":"Pathogens"},{"issue":"null","key":"1537_CR39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/JIR.S347702","volume":"15","author":"J Yang","year":"2022","unstructured":"Yang J, et al. Characterization of the TCR \u03b2 Chain repertoire in peripheral blood from hepatitis B vaccine responders and non-responders. J Inflamm Res. 2022;15(null):939\u201351.","journal-title":"J Inflamm Res"},{"issue":"3","key":"1537_CR40","volume":"1","author":"M Wen","year":"2023","unstructured":"Wen M, et al. Bacterial extracellular vesicles: a position paper by the microbial vesicles task force of the Chinese society for extracellular vesicles. Interdiscip Med. 2023;1(3): e20230017.","journal-title":"Interdiscip Med"},{"issue":"5","key":"1537_CR41","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/HEP.0000000000000438","volume":"78","author":"AS Genshaft","year":"2023","unstructured":"Genshaft AS, et al. Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. Hepatology. 2023;78(5):1525\u201341.","journal-title":"Hepatology"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01537-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:50:45Z","timestamp":1764917445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01537-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01537-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study protocol adhered to the ethical guidelines of the 1975 Declaration of Helsinki and received approval from the Ethics Committee of Institute of The Sixth Affiliated Hospital, South China University of Technology (Approval No. 2023273). The participants were briefed on the study\u2019s purpose and their right to information by the research staff. Before the interview and venous blood collection, written informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"32"}}